A vaccine carrier derived from Neisseria meningitidis with mitogenic activity for lymphocytes.

AUTOR(ES)

Liu, M A

RESUMO

Protein carriers vary in their ability to increase the immunogenicity of poorly immunogenic or T-lymphocyte-independent antigens. We examined one such carrier, the outer membrane protein complex derived from Neisseria meningitidis serogroup B strain B11, in an attempt to determine why this outer membrane protein complex was more immunogenic in young infants and in relevant animal models than two other carriers used in conjugates made with Haemophilus influenzae type b polysaccharide, a T-cell-independent antigen. A single protein of the outer membrane protein complex, the class 2 porin protein, was purified and shown to function as a T-helper lymphocyte carrier protein. Unexpectedly, it was also found to have mitogenic activity for lymphocytes that was not due to lipopolysaccharide. This mitogenic activity appears to date to be unique to this carrier protein of the carrier proteins tested and may contribute to the ability of the H. influenzae type b conjugate vaccine made with the outer membrane protein complex to generate IgG anti-polysaccharide antibody responses in mice and infant monkeys and protective immune responses in infants less than 6 months of age.

Documentos Relacionados

• Release of colony-stimulating activity from thymus-derived lymphocytes.
• Mycoplasma-dependent activation of normal lymphocytes: mitogenic potential of mycoplasmas for mouse lymphocytes.
• Isolation from a Healthy Carrier and Characterization of a Neisseria meningitidis Strain That Is Deficient in γ-Glutamyl Aminopeptidase Activity
• Periodic loss of reactivity of a myeloma tumor with cytotoxic thymus-derived lymphocytes.
• Vaccine Potential of the Neisseria meningitidis 2086 Lipoprotein